摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-Fluoro-2-oxo-1,2-dihydro-4-quinolineacetic acid | 130133-30-1

中文名称
——
中文别名
——
英文名称
7-Fluoro-2-oxo-1,2-dihydro-4-quinolineacetic acid
英文别名
4-(acetic acid)-7-fluoroquinolin-2(1H)-one;2-(7-fluoro-2-oxo-1H-quinolin-4-yl)acetic acid
7-Fluoro-2-oxo-1,2-dihydro-4-quinolineacetic acid化学式
CAS
130133-30-1
化学式
C11H8FNO3
mdl
——
分子量
221.188
InChiKey
IUOAPZODPUAZAN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    224-225 °C
  • 沸点:
    466.4±45.0 °C(Predicted)
  • 密度:
    1.413±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    66.4
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-Fluoro-2-oxo-1,2-dihydro-4-quinolineacetic acid吡啶 、 sodium tetrahydroborate 、 氯化亚砜potassium carbonateN,N-二甲基甲酰胺 、 potassium iodide 作用下, 以 四氢呋喃氯仿N,N-二甲基甲酰胺乙腈 为溶剂, 反应 62.5h, 生成
    参考文献:
    名称:
    Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT1B/5-HT2A receptor antagonists
    摘要:
    Quinolin-2-ones bearing a heteroaryl-piperazine linked by a two carbon chain at the 3- or 4-position were synthesised and evaluated as mixed 5-HT1B/5-HT2A receptor antagonists. Potent mixed antagonists were obtained with thieno[3,2-c]pyridine derivatives. In this series, compound 2.1 (SL 65.0472) proved to be functional antagonist at both the 5-HT2A receptor (rat in vivo 5-HT-induced hypertension model) and the 5-HT1B receptor (dog in vitro saphenous vein assay). (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(01)00118-3
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT1B/5-HT2A receptor antagonists
    摘要:
    Quinolin-2-ones bearing a heteroaryl-piperazine linked by a two carbon chain at the 3- or 4-position were synthesised and evaluated as mixed 5-HT1B/5-HT2A receptor antagonists. Potent mixed antagonists were obtained with thieno[3,2-c]pyridine derivatives. In this series, compound 2.1 (SL 65.0472) proved to be functional antagonist at both the 5-HT2A receptor (rat in vivo 5-HT-induced hypertension model) and the 5-HT1B receptor (dog in vitro saphenous vein assay). (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(01)00118-3
点击查看最新优质反应信息

文献信息

  • Quinolinone derivatives and their preparation in therapy
    申请人:Synthelabo
    公开号:US04983607A1
    公开(公告)日:1991-01-08
    A quinolinone derivative which is a compound of formula (I): ##STR1## in which: R.sub.1 and R.sub.2 are each, independently of one another, a hydrogen or halogen atom or a (C.sub.1-4)alkyl radical; R.sub.3 is a hydrogen atom or a (C.sub.1-4)alkyl radical; R.sub.4 is an unsubstituted or substituted naphthyl, tetrahydronaphthyl, benzyl, phenyl, pyridyl, isoquinolyl or benzoyl radical; and X and Y are each a hydrogen atom or together form a bond; or a pharmaceutically acceptable acid addition salt thereof and, when X and Y are each a hydrogen atom, the diastereoisomers and enantiomers thereof.
    一种喹啉酮衍生物,其化学式为(I):##STR1##其中:R.sub.1和R.sub.2分别独立地是氢原子或卤素原子或(C.sub.1-4)烷基基团;R.sub.3是氢原子或(C.sub.1-4)烷基基团;R.sub.4是未取代或取代的萘基、四氢萘基、苄基、苯基、吡啶基、异喹啉基或苯甲酰基基团;X和Y分别是氢原子或一起形成键;或其药学上可接受的酸盐,当X和Y分别是氢原子时,其对映异构体和对映体。
  • FLUORINATED DERIVATIVE OF QUINOLIN-2(1H)-ONE, METHOD FOR PREPARING THE SAME AND USE THEREOF AS A SYNTHESIS INTERMEDIATE
    申请人:LEGROUX Didier
    公开号:US20100094005A1
    公开(公告)日:2010-04-15
    The invention relates to a fluorinated derivate of quinolin-2(1H)-one (I), to a method for preparing the same, and to the use thereof as an intermediate in the synthesis of 7-fluoro-2-oxo-4-[2-[4-[thieno[3,2-c]pyridine-4-yl)piperazin-1-yl]ethyl]-1,2-dihydro-quinolin-1-acetamide. The invention also relates to the pharmaceutically acceptable salts thereof.
    该发明涉及喹啉-2(1H)-酮的氟化衍生物(I),以及制备该衍生物的方法,以及将其用作合成7-氟-2-氧代-4-[2-[4-[噻吩[3,2-c]吡啶-4-基)哌嗪-1-基]乙基]-1,2-二氢喹啉-1-乙酰胺的中间体。该发明还涉及其药用可接受的盐。
  • MANOURY, PHILIPPE;OBITZ, DANIEL;PEYNOT, MICHEL;FROST, JOHN
    作者:MANOURY, PHILIPPE、OBITZ, DANIEL、PEYNOT, MICHEL、FROST, JOHN
    DOI:——
    日期:——
  • US4983607A
    申请人:——
    公开号:US4983607A
    公开(公告)日:1991-01-08
  • US7943769B2
    申请人:——
    公开号:US7943769B2
    公开(公告)日:2011-05-17
查看更多